ATE489466T1 - Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon - Google Patents

Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon

Info

Publication number
ATE489466T1
ATE489466T1 AT02736569T AT02736569T ATE489466T1 AT E489466 T1 ATE489466 T1 AT E489466T1 AT 02736569 T AT02736569 T AT 02736569T AT 02736569 T AT02736569 T AT 02736569T AT E489466 T1 ATE489466 T1 AT E489466T1
Authority
AT
Austria
Prior art keywords
hairless protein
inhibiting
nucleic acids
protein expression
provides
Prior art date
Application number
AT02736569T
Other languages
English (en)
Inventor
Angela Christiano
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE489466T1 publication Critical patent/ATE489466T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT02736569T 2001-04-13 2002-04-12 Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon ATE489466T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28361801P 2001-04-13 2001-04-13
PCT/US2002/011683 WO2002083891A2 (en) 2001-04-13 2002-04-12 Nucleic acids for inhibiting hairless protein expression and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE489466T1 true ATE489466T1 (de) 2010-12-15

Family

ID=23086858

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736569T ATE489466T1 (de) 2001-04-13 2002-04-12 Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon

Country Status (6)

Country Link
US (3) US7423022B2 (de)
EP (2) EP2327784A3 (de)
JP (1) JP2005510204A (de)
AT (1) ATE489466T1 (de)
DE (1) DE60238395D1 (de)
WO (1) WO2002083891A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083891A2 (en) * 2001-04-13 2002-10-24 The Trustees Of Columbia University In The City Of New York Nucleic acids for inhibiting hairless protein expression and methods of use thereof
US20050233996A1 (en) * 2002-02-20 2005-10-20 Sirna Therapeutics, Inc. RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA)
CA2522184A1 (en) * 2003-04-17 2004-11-04 The Trustees Of Columbia University In The City Of New York Desmoglein 4 is a novel gene involved in hair growth
US8168600B2 (en) 2004-04-23 2012-05-01 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
EP1747022A4 (de) * 2004-04-23 2010-03-31 Univ Columbia Hemmung von haarloser protein mrna
DE102004025881A1 (de) * 2004-05-19 2006-01-05 Beiersdorf Ag Oligoribonukleotide zur Beeinflussung des Haarwachstums
US8568797B2 (en) * 2011-09-13 2013-10-29 Avon Products, Inc Method for enhancing the growth and fullness of hair

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US283618A (en) 1883-08-21 la mont
CA2362320A1 (en) * 1998-01-29 1999-08-05 The Trustees Of Columbia University In The City Of New York Human hairless gene, protein and uses thereof
US6348348B1 (en) * 1998-04-07 2002-02-19 The Carnegie Institution Of Washington Human hairless gene and protein
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002083891A2 (en) * 2001-04-13 2002-10-24 The Trustees Of Columbia University In The City Of New York Nucleic acids for inhibiting hairless protein expression and methods of use thereof

Also Published As

Publication number Publication date
WO2002083891A3 (en) 2002-12-12
US20030077614A1 (en) 2003-04-24
DE60238395D1 (de) 2011-01-05
EP1385948A2 (de) 2004-02-04
WO2002083891A2 (en) 2002-10-24
US20100221318A1 (en) 2010-09-02
EP2327784A3 (de) 2012-11-28
EP2327784A2 (de) 2011-06-01
EP1385948A4 (de) 2005-07-20
US20090004169A1 (en) 2009-01-01
US7423022B2 (en) 2008-09-09
EP1385948B1 (de) 2010-11-24
US8008471B2 (en) 2011-08-30
JP2005510204A (ja) 2005-04-21

Similar Documents

Publication Publication Date Title
ATE430759T1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
DE60210265D1 (de) Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren
EP1408945A4 (de) Verfahren, verbindungen und zusammensetzungen zur reduzierung von körperfett und zur modulierung des fettsäurestoffwechsels
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
EP1438054A4 (de) Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren mit 4'-modifiziertem nucleosid
EP1248794A4 (de) Antisens-modulierung der smad7 expression
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE602004031462D1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
DE60223250D1 (de) Verfahren zur herstellung von alpha-hydroxysäure, glycolsäure und 2-hydroxyisobuttersäure aus dem entsprechenden alpha-hydroxynitril mittels nitrilase
EP1416953A4 (de) Verfahren zur behandlung von leberfibrose
ATE345681T1 (de) Verfahren zur herstellung von antimikrobiellen parfümierenden zusammensetzungen
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE489466T1 (de) Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE359816T1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
WO2003057843A3 (en) Methods and materials for modulating trpc4
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
HUP0402327A2 (hu) Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása
DE60134234D1 (de) Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese
BR0013228A (pt) Método e composições utilizados para modulação de angiogenese usando proteìna quinase raf e ras
WO2003057847A8 (en) METHODS AND MATERIALS FOR MODULATING ENaC-BETA
DE50205026D1 (de) Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen
DE60333747D1 (de) Dna-enzym zur hemmung von plasminogenaktivator-inhibitor-1
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties